Asymmetrical Dimethylarginine: The Über Marker?

Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease

Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107

Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction

Suwaidi, J. M. S. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,044

Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors

Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia

Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087

Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease

Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Nedeljkovic, Z. S., Menzoı́an, J. O., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00333-4 · Cited by 776

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 763

Endogenous Nitric Oxide Synthase Inhibitor

Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756

NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease

Cooke, J. P., & Dzau, V. J. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 706

Asymmetric Dimethylarginine and Cardiac Allograft Vasculopathy Progression

Potena, L., Fearon, W. F., Sydow, K., Holweg, C. T. J., Luikart, H. I., Chin, C. C., Weisshaar, D., Mocarski, E. S., Lewis, D. B., Valantine, H. A., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e318166a3a4 · Cited by 21

Polymorphisms of Homocysteine Metabolism Are Associated with Intracranial Aneurysms

Semmler, A., Linnebank, M., Krex, D., Götz, A., Moskau, S., Ziegler, A., & Simon, M. (2008) · Cerebrovascular Diseases · doi:10.1159/000155638 · Cited by 21

Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects

Marra, M., Marchegiani, F., Ceriello, A., Sirolla, C., Boemi, M., Franceschi, C., Spazzafumo, L., Testa, I., Bonfigli, A. R., Cucchi, M., et al. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs516 · Cited by 21

Assessment of endothelial (dys)function in atrial fibrillation

Krishnamoorthy, S., Lim, S., & Lip, G. Y. H. (2009) · Annals of Medicine · doi:10.1080/07853890903160726 · Cited by 21

The Role of Oxidative Stress in Endothelial Dysfunction and Vascular Inflammation

Osto, E., & Cosentino, F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00022-8 · Cited by 23

Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: Effect of 12-month growth hormone replacement therapy

Marco, S. D., Marcovecchio, M. L., Caniglia, D., Leonibus, C. D., Chiarelli, F., & Mohn, A. (2014) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2014.08.001 · Cited by 20

Increased brachial intima-media thickness is associated with circulating levels of asymmetric dimethylarginine in patients with COPD

Urban, M. H., Eickhoff, P., Funk, G., Burghuber, O. C., Wolzt, M., & Valipour, A. (2017) · International Journal of COPD · doi:10.2147/copd.s118596 · Cited by 20

Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population

Zhu, W., & Hong, K. (2017) · International Heart Journal · doi:10.1536/ihj.16-208 · Cited by 20

Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis

Lluch, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i32.9466 · Cited by 21

Dietary nitrate, nitric oxide, and restenosis

Cooke, J. P., & Ghebremariam, Y. T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57193 · Cited by 19

Relations between Concentrations of Asymmetric Dimethylarginine and Neopterin as Potential Risk Factors for Cardiovascular Diseases in Haemodialysis-Treated Patients

Avcı, E., Cevher, Ş. C., Çakır, E., Kurt, Y., Akgül, E. Ö., & Bilgi, C. (2008) · Renal Failure · doi:10.1080/08860220802249009 · Cited by 19

Assessment of endothelial dysfunction

Freestone, B., Krishnamoorthy, S., & Lip, G. Y. H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.184 · Cited by 19

Nitric Oxide Pathway Activation and Impaired Red Blood Cell Deformability with Hypercholesterolemia

Kuwai, T., & Hayashi, J. (2006) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.13.286 · Cited by 19

Asymmetric Dimethylarginine in Response to Recombinant Tissue-Type Plasminogen Activator and Erythropoietin in Acute Stroke

Worthmann, H., Martens‐Lobenhoffer, J., Joumaah, M., Li, N., Lichtinghagen, R., Hecker, H., Kielstein, J. T., Ehrenreich, H., Bode‐Böger, S. M., & Weißenborn, K. (2013) · Stroke · doi:10.1161/strokeaha.113.001145 · Cited by 19

The Kidney and Periodontal Disease (KAPD) study: A pilot randomized controlled trial testing the effect of non-surgical periodontal therapy on chronic kidney disease

Grubbs, V., Garcia, F., Jue, B., Vittinghoff, E., Ryder, M. I., Lovett, D. H., Carrillo, J., Offenbacher, S., Ganz, P., Bibbins-Domingo, K. B., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.017 · Cited by 19

High asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in migraine patients

Reyhani, A., Çelik, Y., Karadağ, Ç. H., Gündüz, Ö., Asıl, T., & Süt, N. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2970-1 · Cited by 18

l-Homoarginine and its AGXT2-metabolite GOCA in chronic kidney disease as markers for clinical status and prognosis

Martens‐Lobenhoffer, J., Emrich, I. E., Zawada, A. M., Fliser, D., Wagenpfeil, S., Heine, G. H., & Bode‐Böger, S. M. (2018) · Amino Acids · doi:10.1007/s00726-018-2610-y · Cited by 17

Plasma ADMA concentrations associate with aerobic fitness in postmenopausal women

Tanahashi, K., Akazawa, N., Miyaki, A., Choi, Y., Ra, S., Matsubara, T., Kumagai, H., Oikawa, S., Miyauchi, T., & Maeda, S. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.05.003 · Cited by 17

The relationship of nitric oxide synthesis capacity, oxidative stress, and albumin-to-creatinine ratio in black and white men: the SABPA study

Mels, C. M. C., Huisman, H. W., Smith, W. T., Schutte, R., Schwedhelm, E., Atzler, D., Böger, R. H., Ware, L. J., & Schutte, A. E. (2016) · AGE · doi:10.1007/s11357-016-9873-6 · Cited by 17

Hyperthyroid cats and their kidneys: a literature review

Yu, L., Lacorcia, L., & Johnstone, T. (2022) · Australian Veterinary Journal · doi:10.1111/avj.13179 · Cited by 17

Possible Indirect Detection of rHuEPO Administration in Human Urine by High-Performance Liquid Chromatography Tandem Mass Spectrometry

Appolonova, S. A., Dikunets, M. A., & Rodchenkov, G. M. (2008) · European Journal of Mass Spectrometry · doi:10.1255/ejms.922 · Cited by 17

Dimethylarginines in complicated type 1 diabetes: Roles of insulin, glucose, and oxidative stress

Cighetti, G., Fermo, I., Aman, C. S., Ferraroni, M., Secchi, A., Fiorina, P., & Paroni, R. C. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.05.007 · Cited by 17

ADMA: an emerging cardiovascular risk factor

Böger, R. H., Cooke, J. P., & Vallance, P. J. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm594ed · Cited by 18

Correlates of arterial stiffness in an ageing population: Role of asymmetric dimethylarginine

Ngo, D. T. M., Sverdlov, A. L., McNeil, J. J., & Horowitz, J. D. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.006 · Cited by 16

Extensive characterization of the human DDAH1 transgenic mice

Schwedhelm, E., von Leitner, E.-C., Atzler, D., Schmitz, C., Jacobi, J., Meinertz, T., Münzel, T. F., Baldus, S. E., Cooke, J. P., Böger, R. H., et al. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.08.001 · Cited by 16

Serum Markers for the Prediction of Preeclampsia

Angeliki, G. D. (2014) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000264 · Cited by 16

Enlarged Size and Impaired Elastic Properties of the Ascending Aorta are Associated with Endothelial Dysfunction and Elevated Plasma Matrix Metalloproteinase-2 Level in Patients with Bicuspid Aortic Valve

Wang, Y., Li, Y., Deng, Y., Liu, Y., Zhang, J., Sun, J., Zhu, Y. Y., Li, L., Tang, Q.-Y., & Zhou, W. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.01.012 · Cited by 16

DDAH: A target for vascular therapy?

Cooke, J. P. (2010) · Vascular Medicine · doi:10.1177/1358863x10362605 · Cited by 16

Nonsurgical Periodontal Therapy in CKD: Findings of the Kidney and Periodontal Disease (KAPD) Pilot Randomized Controlled Trial

Grubbs, V., Garcia, F., Vittinghoff, E., Jue, B., Ryder, M. I., Lovett, D. H., Offenbacher, S., Taylor, G. W., Ganz, P., Bibbins-Domingo, K. B., et al. (2019) · Kidney Medicine · doi:10.1016/j.xkme.2019.09.005 · Cited by 16

Increased Plasma Nitrite and von Willebrand Factor Indicates Early Diagnosis of Vascular Diseases in Chemotherapy Treated Cancer Patients

Giri, S., Bose, J. C., Ajay, C., Tiwary, B. K., Gajalakshmi, P., & Chatterjee, S. (2018) · Cardiovascular Toxicology · doi:10.1007/s12012-018-9471-1 · Cited by 15

Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile

Ferrigno, A., Rizzo, V., Bianchi, A., Pasqua, L. G. D., Berardo, C., Richelmi, P., & Vairetti, M. (2014) · BioMed Research International · doi:10.1155/2014/627434 · Cited by 15

Vascular compliance versus flow-mediated vasodilation: correlation with cardiovascular risk factors

Nair, N., Oka, R. K., Waring, L. D., Umoh, E. M., Taylor, C. B., & Cooke, J. P. (2005) · Vascular Medicine · doi:10.1191/1358863x05vm633oa · Cited by 15

Metabolic Syndrome and Preeclampsia

Hubel, C. A., & Roberts, J. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374213-1.00007-0 · Cited by 15

Decline of popliteal artery flow-mediated dilation with aging and possible involvement of asymmetric dimethylarginine in healthy men

Nakamura, A., Kajitani, S., Sato, K., Kanazawa, M., Kondo, M., Endo, H., & Nozaki, E. (2019) · Journal of Medical Ultrasonics · doi:10.1007/s10396-019-00946-2 · Cited by 15

Treatment with niacin lowers ADMA

Westphal, S., Borucki, K., Luley, C. H., Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.11.018 · Cited by 15

High Levels of Asymmetric Dimethylarginine Are Strongly Associated with Low HDL in Patients with Acute Myocardial Infarction

Lorin, J., Guilland, J.-C., Korandji, C., Touzery, C., Bichât, F., Chagnon, A., Cottin, Y., Rochette, L., Vergely, C., & Zeller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064796 · Cited by 16

Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation

Yang, L., Qu, X., Shuqin, S., Yu, Y., Ying, S., Yanwei, Y., Wei, F., & Yin, D. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9588-7 · Cited by 14

Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina

Surdacki, A., Marewicz, E., Wieczorek‐Surdacka, E., Rakowski, T., Szastak, G., Pryjma, J. R., Dudek, D., & Dubiel, J. S. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp439 · Cited by 14

Atherosclerosis and the Glu298Asp Polymorphism of the eNOS Gene in White Patients With End-Stage Renal Disease

Spoto, B., Benedetto, F., Testa, A., Tripepi, G. L., Mallamaci, F., Maas, R., Boeger, R. H., & Zoccali, C. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.06.007 · Cited by 14

Abdominal Obesity is Associated with Peripheral Artery Disease in Hemodialysis Patients

Hung, P., Tsai, H., Lin, C., & Hung, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067555 · Cited by 14

Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus

Kanazawa, I., Yano, S., Yamaguchi, T., Notsu, Y., Nabika, T., & Sugimoto, T. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03828.x · Cited by 13

Asymmetric dimethylarginine and angiogenesis: biological significance

Wieczór, A. M., Wieczór, R., Kulwas, A., & Rość, D. (2018) · International Angiology · doi:10.23736/s0392-9590.18.04017-8 · Cited by 13

The Continuum of Risk

Hirsch, A. T., & Folsom, A. R. (2004) · Circulation · doi:10.1161/01.cir.0000147616.76919.99 · Cited by 13

Should We Measure Asymmetric Dimethylarginine in Patients with Coronary Artery Disease?

Kielstein, J. T., & Cooke, J. P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.078881 · Cited by 13

Plasma asymmetric dimethylarginine, l-arginine and left ventricular structure and function in a community-based sample

Lieb, W., Benndorf, R. A., Benjamin, E. J., SULLIVAN, L. M., Maas, R., Xanthakis, V., Schwedhelm, E., Aragam, J. R., Schulze, F., Böger, R. H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.018 · Cited by 12

IGF-1 and ADMA Levels Are Inversely Correlated in Nondiabetic Ankylosing Spondylitis Patients Undergoing Anti-TNF-Alpha Therapy

Genre, F., López‐Mejías, R., Rueda‐Gotor, J., Miranda-Filloy, J. A., Ubilla, B., Villar-Bonet, A., Carnero-López, B., Gómez‐Acebo, I., Blanco, R., Pina, T., et al. (2014) · BioMed Research International · doi:10.1155/2014/671061 · Cited by 12

Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?

Németh, B., PÉTER, I. A., Boncz, I., Jagicza, A., Kiss, I., Csergő, Á., Kőszegi, T., Kustán, P., Horváth, I., & Ajtay, Z. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s197633 · Cited by 12

Arginine methylation dysfunction increased risk of acute coronary syndrome in coronary artery disease population

Zhang, S., Zhang, S., Wang, H., Wu, W., & Ye, Y. (2017) · Medicine · doi:10.1097/md.0000000000006074 · Cited by 12

Cadmium, smoking, and reduced levels of exhaled nitric oxide among US adults

Min, J., & Min, K. (2013) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2013.07.001 · Cited by 11

Asymmetric Dimethylarginine in Obesity After Renal Transplantation

Teplan, V., Schück, O., Ráček, J., Lecian, D., Haluzı́k, M., Kudla, M., & Vitko, S. (2008) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2008.05.005 · Cited by 11

Proton Pump Inhibitor Exposure and Acute Myocardial Infarction Risk: A Nested Cohort Study

Tseng, H.-J., Cheng, C., Tsai, S., Lin, W.-C., Bai, Y., Tsai, C.-F., Su, T., Li, C., Chen, T., & Chen, M. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-021-09637-2 · Cited by 11

Impact of pre-angiogenic factors on the treatment effect of bevacizumab in patients with metastatic colorectal cancer

Dirican, A., Küçükzeybek, Y., Alacacıoğlu, A., Varol, U., Aksun, S., Bayoğlu, İ. V., Demir, L., Çoban, E., Sütçü, R., & Tarhan, M. O. (2014) · Medical Oncology · doi:10.1007/s12032-014-0905-8 · Cited by 11

Association between Asymmetric Dimethylarginine and Neopterin in Patients with and without Angiographic Coronary Artery Disease

Murr, C., Meinitzer, A., Grammer, T. B., Schroecksnadel, K., Böhm, B. O., März, W., & Fuchs, D. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02261.x · Cited by 11

Nitric Oxide Manipulation: A Therapeutic Target for Peripheral Arterial Disease?

Williams, G. H., Shiwen, X., Abraham, D., Selvakumar, S., Baker, D., & Tsui, J. C. S. (2012) · Cardiology Research and Practice · doi:10.1155/2012/656247 · Cited by 11

Biologie du vieillissement artériel et artériosclérose

Cottart, C., Laguillier, C., Nivet‐Antoine, V., Klimczak, C., Sebban, C., & Beaudeux, J. (2008) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2008.10.002 · Cited by 24

Primary and Secondary Hypertension

Blumenfeld, J. D., Liu, F., & Laragh, J. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10046-6 · Cited by 11

Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study

Bima, C., Parasiliti‐Caprino, M., Rumbolo, F., Ponzetto, F., Gesmundo, I., Nonnato, A., Fornengo, P., Vaula, G., Ghigo, E., Mengozzi, G., et al. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.03.015 · Cited by 10

High clinical accuracy of asymmetric dimethylarginine and symmetric dimethylarginine in patients with ischemic heart disease

Djordjević, B. V., Pavlović, R., Ćosić, V., Deljanin-Ilić, M., Ristić, T., Krstić, N., & Jevtović−Stoimenov, T. (2012) · Amino Acids · doi:10.1007/s00726-012-1307-x · Cited by 10

CLINICAL IMPORTANCE OF BIOCHEMICAL MARKERS OF CARDIAC DAMAGE IN HEMODIALYSIS PATIENTS

Petrović, D., Jagić, N., Miloradović, V., & Stojimirovic, B. B. (2008) · Serbian Journal of Experimental and Clinical Research · Cited by 10

Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis

Golonka, R. M., Cooper, J. K., Issa, R., Devarasetty, P. P., Gokula, V., Busken, J., Zubcevic, J. A., Hill, J. W., Vijay–Kumar, M., Menon, B., et al. (2021) · Current Hypertension Reports · doi:10.1007/s11906-021-01142-9 · Cited by 10

The effect of rosiglitazone on asymmetric dimethylarginine (ADMA) in critically ill patients

Richir, M. C., Ellger, B., Teerlink, T., Siroen, M. P. C., Visser, M., Spreeuwenberg, M. D., Girbes, A. R. J., van der Hoven, B., den Berghe, G. V., Wilhelm, A. J., et al. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.06.007 · Cited by 10

Arterial elasticity is associated with endothelial vasodilatory function and asymmetric dimethylarginine level in healthy subjects

Kals, J., Kampus, P., Kals, M., Teesalu, R., Zilmer, K., Pulges, A., & Zilmer, M. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510701203470 · Cited by 10

Medium-term methionine supplementation increases plasma homocysteine but not ADMA and improves blood pressure control in rats fed a diet rich in protein and adequate in folate and choline

Mariotti, F., Hammiche, A., Blouet, C., Daré, S., Tomé, D., & Huneau, J. (2006) · European Journal of Nutrition · doi:10.1007/s00394-006-0611-1 · Cited by 10

Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension

Pullamsetti, S. S., Kiss, L., Ghofrani, H. A., Voswinckel, R., Haredza, P., Klepetko, W., Aigner, C., Fink, L., Muyal, J. P., Weißmann, N., et al. (2005) · BMC Pharmacology · doi:10.1186/1471-2210-5-s1-p45 · Cited by 10

Angiotensin-converting Enzyme Inhibition Improves the Effectiveness of Transcutaneous Carbon Dioxide Treatment

Németh, B., Kiss, I., JENCSIK, T., PÉTER, I. A., KRESKA, Z., Kőszegi, T., Miseta, A., Kustán, P., Boncz, I., LACZO, A., et al. (2017) · In Vivo · doi:10.21873/invivo.11077 · Cited by 10

Pharmacological treatment of HIV-associated pulmonary hypertension

Chinello, P., & Petrosillo, N. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1151785 · Cited by 9

Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol

Oliva-Dámaso, E., Oliva-Dámaso, N., Rodríguez‐Esparragón, F., Payán, J., Marañes, A., López, Y. P., Baamonde-Laborda, L. E., Díaz, N. V., & Rodríguez-Pérez, J. C. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.10.002 · Cited by 8

Metabolomic markers mediate erythrocyte anisocytosis in older adults: Results from three independent aging cohorts

Tian, Q., Mitchell, B. A., Moaddel, R., Zoccali, C., Bandinelli, S., & Ferrucci, L. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13612 · Cited by 8

The endotoxin/toll-like receptor-4 axis mediates gut microvascular dysfunction associated with post-prandial lipidemia

Yi, P., Pang, J., Alexander, J. S., & Rivera, C. A. (2013) · BMC Physiology · doi:10.1186/1472-6793-13-12 · Cited by 8

Asymmetric dimethylarginine as a prognostic marker for cardiovascular complications in hypertensive patients

Tayeh, O. M., Fahmi, A., Islam, M., & Saied, M. (2011) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2011.09.004 · Cited by 8

Asymmetric Dimethylarginine Attenuates the Association of Melatonin Secretion With Night-Time Blood Pressure and Dipping in Elderly Individuals

Obayashi, K., Saeki, K., & Kurumatani, N. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0613 · Cited by 8

Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits

Lin, Y., Feng, M., Lu, C.-W., Lei, Y., He, Z., & Xiong, Y. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.041 · Cited by 8

Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction

Tsioufis, C. P., Aggelis, A., Dimitriadis, K. S., Thomopoulos, C., Kasiakogias, A., Tzamou, V., Kyvelou, S.-M., Mikhailidis, D. P., Papademetriou, V., & Stefanadis, C. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.642868 · Cited by 7

The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression

Hudson, C. L., Zemlin, A. E., & Ipp, H. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213505848 · Cited by 7

The Pathophysiology of Uremia

Abramowitz, M. K., Meyer, T. W., & Hostetter, T. H. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0987-2.00018-2 · Cited by 7

Response of Asymmetric Dimethylarginine to Hemodialysis-Associated Hypotension in End-Stage Renal Disease Patients

Csiky, B. S., Sulyok, E., Lakatos, O., Wittmann, I., Martens‐Lobenhoffer, J., & Bode‐Böger, S. M. (2008) · Nephron Clinical Practice · doi:10.1159/000114451 · Cited by 7

Synergistic Association of Metabolic Syndrome and Overt Nephropathy With Elevated Asymmetric Dimethylarginine in Serum and Impaired Cutaneous Microvasodilation in Patients With Type 2 Diabetes

Yamamoto, R., & Aso, Y. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-2534 · Cited by 7

Nitric Oxide–Asymmetric Dimethylarginine System in Endothelial Cell Senescence

Scalera, F., & Bode‐Böger, S. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373866-0.00014-9 · Cited by 6

Proteomic analysis of urethral protein expression in an estrogen receptor α-deficient murine model of stress urinary incontinence

Chen, Y., Chen, C., Lin, Y.-N., Wu, Y., Hsieh, W., Wu, B.-T., Ma, W., Chen, W., Tsai, K.-S., Wu, S.-Y., et al. (2015) · World Journal of Urology · doi:10.1007/s00345-014-1474-3 · Cited by 6

The effect of nitric oxide, endothelial nitric oxide synthetase, and asymmetric dimethylarginine in hemorrhoidal disease

Gökçe, A. H., Gökçe, F. S., Durmuş, S., Hajiyeva, R., Ersöz, F., Gelışgen, R., & Uzun, H. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.8.1128 · Cited by 6

Cardiotoxic Effects Produced by Omeprazole and Methylene Blue in an Animal Model of Cardiac Ischemia and Reperfusion and Potential Implications for the Pharmacological Strategy for Vasoplegic Syndrome

de Araújo, E. A., Tallo, F. S., Oliveira, A. S. F., Toghlobi, G. S. S. E., Arantes, R. A., Balsimelli, R., Kehrwald-Balsimelli, B., Viana, B. L. D. A., Matuda, F. S., Nicolau, L. A. D., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12030582 · Cited by 6

Asymmetric Dimethylarginine (ADMA) and Progression of Nephropathy in Patients with Type 2 Diabetes

Assal, H. S., Younes, K., Alsayed, A., Hasan, N. S., & Ali, A. R. (2009) · Kidney · doi:10.1007/s00596-009-0115-0 · Cited by 6

Metabolic Syndrome and Preeclampsia

Jeyabalan, A., Hubel, C. A., & Roberts, J. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407866-6.00007-9 · Cited by 6

Acetylation of asymmetric and symmetric dimethylarginine: an undercharacterized pathway of metabolism of endogenous methylarginines

Rodionov, R. N., Martens‐Lobenhoffer, J., Brilloff, S., Burdin, D. V., Jarzebska, N., Demyanov, A. V., Hohenstein, B., Weiss, N., & Bode‐Böger, S. M. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv390 · Cited by 6

Omeprazole suppresses endothelial calcium response and eNOS Ser1177 phosphorylation in porcine aortic endothelial cells

Kamiya, C., Odagiri, K., Hakamata, A., Sakurada, R., Inui, N., & Watanabe, H. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06561-0 · Cited by 6

Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization

Fröbert, O., Hjortshøj, S. P., Simonsen, U., & Ravkilde, J. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.04.152 · Cited by 7

Cigarettes and ADMA: The Smoke Hasn’t Cleared Yet

Kielstein, J. T., Peter, C., & Adams, M. C. (2006) · Hypertension · doi:10.1161/01.hyp.0000240013.09503.0a · Cited by 6

Cardiovascular disease: primary prevention, disease modulation and regenerative therapy

Sultan, S., & Hynes, N. (2012) · Vascular · doi:10.1258/vasc.2012.ra0062 · Cited by 5

Effect of Lowering Asymmetric Dimethylarginine (ADMA) on Vascular Pathology in Atherosclerotic ApoE-Deficient Mice with Reduced Renal Mass

Jacobi, J., Maas, R., Arend, M., Cordasic, N., & Hilgers, K. F. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045522 · Cited by 5

Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study

Kei, A. A., Elisaf, M., Moutzouri, E., Tsiara, S., & Liberopoulos, E. N. (2011) · International Journal of Hypertension · doi:10.4061/2011/830434 · Cited by 5

Hormone therapy and asymmetrical dimethylarginine in postmenopausal women

Karkanaki, A., Vavilis, D., Traianos, A., Kalogiannidis, I. A., & Panidis, D. (2010) · HORMONES · doi:10.14310/horm.2002.1262 · Cited by 5

Arginine Metabolism, Pulmonary Hypertension, and Sickle Cell Disease—Reply

Morris, C. R., Vichinsky, E. P., Kato, G. J., Gladwin, M. T., Hazen, S. L., & Morris, S. M. (2005) · JAMA · doi:10.1001/jama.294.19.2433-b · Cited by 5

Arginine/Asymmetric Dimethylarginine Ratio in Colorectal Surgery

Ragina, N. P., Davis, G., Doorly, M. G., Cologne, K. G., & Senagore, A. J. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr2988w · Cited by 5

Resistance of Statin Therapy, and Methods for its Influence

Vladimirova‐Kitova, L., & Kitov, S. I. (2015) · InTech eBooks · doi:10.5772/60004 · Cited by 6

Lowering Asymmetric Dimethylarginine – A New Mechanism Mediating the Renoprotective Effects of Renin-Angiotensin System Inhibitors in Proteinuric Patients?

Kielstein, J. T., & Fliser, D. (2007) · Blood Purification · doi:10.1159/000107409 · Cited by 5

Guanidine-Modifying Enzymes in the Pentein Superfamily

Linsky, T. W., & Fast, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00170-2 · Cited by 5

Arginine Metabolism, Pulmonary Hypertension, and Sickle Cell Disease

Kielstein, J. T., & Cooke, J. P. (2005) · JAMA · doi:10.1001/jama.294.19.2433-a · Cited by 5

Endothelial Impairment in HIV-Associated Preeclampsia: Roles of Asymmetric Dimethylarginine and Prostacyclin

Mthembu, M. H., Sibiya, S., Moodley, J., Mkhwanazi, N. P., & Naicker, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157451 · Cited by 4

Increased asymmetric dimethylarginine in vitamin B12 deficient adolescents

Dündar, M. A., Torun, Y. A., Çelik, S. F., Tartıcı, E. K., & Karakükçü, Ç. (2019) · Cardiology in the Young · doi:10.1017/s104795111800207x · Cited by 4

Endogenous Symmetric Dimethylarginine (SDMA) and Asymmetrical Dimethylarginine (ADMA) Levels in Healthy Cows and Cows with Subclinical and Clinical Mastitis—A Comparative Study

Bronzo, V., Sala, G., Ciabattini, I., Orsetti, C., Armenia, G., Meucci, V., Marchi, L. D., Bertelloni, F., Sgorbini, M., & Bonelli, F. (2025) · Animals · doi:10.3390/ani15040527 · Cited by 4

Asymmetric Dimethylarginine and Atherosclerosis

Qin, J. (2003) · Advances in Cardiovascular Diseases

Asymmetric Dimethylarginine and Cerebrovascular Disorders in Humans

Tsuda, K. (2006) · Stroke · doi:10.1161/01.str.0000248209.76578.3a

Original Article Handling of asymmetrical dimethylarginine and symmetrical

Nijveldt, R. J., Teerlink, T., Guldener, C. V., Prins, H. A., van Lambalgen, A. A., Stehouwer, C. D. A., Rauwerda, J. A., & van Leeuwen, P. A. M. (2015)

Do Homoarginine and Asymmetric Dimethylarginine Act Antagonistically in the Cardiovascular System?

Tsikas, D., & Kayacelebi, A. A. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0484 · Cited by 35

Abstract 4054: Determinants of Circulating Asymmetric Dimethylarginine, Monomethylarginine and L-Arginine: A Population-Based Study

Chirinos, J. A., Lezama, J. M., David, R., Bralley, J. A., Vargas, O. L. M., Zea-Díaz, H., Bolaños, J., Valdivia-Ascuña, Z., Diaz, S. P., Medina, F. F. C., et al. (2006) · Circulation